about
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overa...
Read More
85.48
1.36
(1.62%)
11.6M
XNYS Volume
XNYS 02 Sep, 2025 5:30 PM (EDT)
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest.
View Similar
Embed DVM
Merck & Company Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..